ArticleOncotarget2017
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients.
Gong Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it